Table 4. Synopsis of published epidemiological data for acute liver failure (ALF) in the past decade.
Author | Country or region | Cohort or population | Study design | Number of people | Incidence (in 100.000 person-years) |
All causes of ALF | |||||
Bretherick et al. 2011 (21) | Scotland | Residents of a geographically defined area including Edinburgh | Retrospective cohort study, data from the Scottish Liver Transplant Unit at the Royal Infirmary of Edinburgh | ˜5 064 200 | 0.62 |
Ho et al. 2014 (5) | Taiwan | Taiwanese population | Population-based study, data randomly selected from the Longitudinal Health Insurance Database | 1 000 000 | 8.02 |
Thanapirom et al. 2019 (22) | Thailand | Thai population | Population-based study, data from the statutory Universal Coverage Scheme (76% of all admissions to primary, secondary, and tertiary hospitals across 77 provinces) | ˜65 400 000 | 6.29 |
Drug-induced liver injury | |||||
Goldberg et al. 2015 (26) | California, USA | Northern California residents | Retrospective cohort study, data from the Kaiser Permanente Northern California Health Care health insurance service | ˜2 400 000 | 0.19 |
Shen et al. 2019 (29) | China | Patients of 66 centers in mainland China | Retrospective cohort study with extrapolation to the population of mainland China | ˜1 361 000 000* | 23.8 |
* Extrapolation to this number of people